Real-time enrollment status for this b-cell non-hodgkin lymphoma clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 5:31 PM UTC
| NCT Number | NCT05365659 |
| Recruiting Status | Recruiting |
| Condition | B-cell Non-Hodgkin Lymphoma |
| Phase | PHASE1 |
| Target Enrollment | 140 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Iksuda Therapeutics Ltd. |
| Last Updated on CT.gov | July 29, 2026 (Jul 29, 2026) |
As of October 12, 2026: Clinical trial NCT05365659 is currently recruiting participants. This phase1 study for b-cell non-hodgkin lymphoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Iksuda Therapeutics Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05365659 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05365659 was last updated Jul 29, 2026 (July 29, 2026). HelloStudys verifies this status automatically.